Using Machine Learning to Predict Final HER2 Status in Invasive Breast Cancer Cases that are Equivocal (2+) by Immunohistochemistry

被引：0
|
作者：
Rasmussen, Sean [1 ,2 ]
Taylor, Valerie [2 ]
Surette, Alexi [3 ]
Barnes, Penny [1 ,2 ]
Bethune, Gillian [1 ,2 ]
机构：
[1] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Vitalite Hlth Network, Moncton, NB, Canada
来源：
MODERN PATHOLOGY | 2022年 / 35卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
164
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [41] The relation between percentage of immunostained cells and amplification status in breast cancers with equivocal result for Her2 immunohistochemistry
    Onguru, Onder
    Zhang, Paul J.
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (05) : 381 - 384
  • [42] Analysis of equivocal HER2 FISH amplification in breast cancer
    Sung, S. H.
    Moon, B. I.
    HISTOPATHOLOGY, 2012, 61 : 30 - 30
  • [43] Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
    Lee, Andrew H. S.
    Key, Heather P.
    Bell, Jane A.
    Hodi, Zsolt
    Ellis, Ian O.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (06) : 490 - 492
  • [44] HER2 status in breast cancer: immunohistochemistry and gene amplification in the Republic of Kazakhstan
    Lyubko, S.
    Satbaeva, E.
    VIRCHOWS ARCHIV, 2019, 475 : S73 - S74
  • [45] Stratification of breast carcinomas with double-equivocal HER2 status
    Marchio, C.
    Trisolini, E.
    Maletta, F.
    Annaratone, L.
    Scalzo, M. S.
    Mascali, D.
    di Cantogno, L. Verdun
    Medico, E.
    Sapino, A.
    CANCER RESEARCH, 2016, 76
  • [46] Correlation of Hormone Receptor and HER2 Status Between RT-PCR and Immunohistochemistry in Invasive Breast Cancer
    Meindl, Amanda
    Noncent, Edernst
    Finkelman, Brian
    Shen, Tiansheng
    Blanco, Luis
    Siziopikou, K. P.
    Pincus, Jennifer
    LABORATORY INVESTIGATION, 2019, 99
  • [47] Correlation of Hormone Receptor and HER2 Status Between RT-PCR and Immunohistochemistry in Invasive Breast Cancer
    Meindl, Amanda
    Noncent, Edernst
    Finkelman, Brian
    Shen, Tiansheng
    Blanco, Luis
    Siziopikou, K. P.
    Pincus, Jennifer
    MODERN PATHOLOGY, 2019, 32
  • [48] Utility of HER2 IHC intensity in selecting areas for FISH testing in equivocal (2+) cases
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen A.
    O'Connor, Siobhan
    Calhoun, Benjamin
    CANCER RESEARCH, 2020, 80 (04)
  • [49] Radiomics to predict HER2 status in breast cancer brain metastases
    Griguolo, G.
    Gabelloni, M.
    Fusco, R.
    Jacot, W.
    Guarascio, M. C.
    Francischello, R.
    Bauchet, L.
    Granata, V.
    Faggioni, L.
    Bottosso, M.
    Rigau, V.
    Dieci, M. V.
    Neri, E.
    Darlix, A.
    Guarneri, V.
    ANNALS OF ONCOLOGY, 2023, 34 : S382 - S383
  • [50] HER2 Status in Breast biopsy: How reliable is Immunohistochemistry?
    Lebeau, A.
    Turzynski, A.
    Braun, S.
    Behrhof, W.
    Fleige, B.
    Schmitt, W.
    Grob, T.
    Burkhardt, L.
    Jackisch, C.
    Thomssen, C.
    Mueller, V.
    Untch, M.
    ONKOLOGIE, 2010, 33 : 13 - 13
12345